ConductScience.org, home

Paper632576

The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.

Lipsky PE and 1 other. J Immunol, 1978. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. Papers, record 632576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/632576

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
PubMed
Journal
J Immunol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
4.45
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lipsky PEP E
2Ziff MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CopperMajor topic
Lymphocyte ActivationMajor topic
MitogensMajor topic
PenicillamineMajor topic
Acetates
Chlorides
Gold
Humans
Sulfates
Sulfhydryl Compounds
Time Factors

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
41198664Decoding cuproptosis and cuproplasia: implications for therapeutic strategies in renal cell carcinoma.Cell Death Discov2025https://conductscience.org/library/papers/41198664PubMed
40809021Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma.Front Oncol2025https://conductscience.org/library/papers/40809021PubMed
38486750Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.Heliyon2024https://conductscience.org/library/papers/38486750PubMed
34604310Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.Front Mol Biosci2021https://conductscience.org/library/papers/34604310PubMed
34071639D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.Antibiotics (Basel)2021https://conductscience.org/library/papers/34071639PubMed
26692151Wilson's disease: A review of what we have learned.World J Hepatol2015https://conductscience.org/library/papers/26692151PubMed
22358565Cytotoxicity of D-penicillamine in association with several heavy metals against cultured rabbit articular chondrocytes.Cytotechnology1988https://conductscience.org/library/papers/22358565PubMed
8202663Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.Rheumatol Int1994https://conductscience.org/library/papers/8202663PubMed
7136959Antiulcer activities of D-penicillamine copper complexes.Agents Actions1982https://conductscience.org/library/papers/7136959PubMed
7075029In vitro monocyte-lymphocyte interaction influenced by d-penicillamine.Clin Exp Immunol1982https://conductscience.org/library/papers/7075029PubMed
7034252Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.Springer Semin Immunopathol1981https://conductscience.org/library/papers/7034252PubMed
6976356
Production of antibodies specific for Fc, Fab', and streptokinase-streptodornase in vitro by peripheral blood cells from patients with rheumatoid arthritis and normal donors. Identification of immune complexes in culture supernatants containing hidden antibodies reactive with Fab' fragments of immunoglobulin G.
J Clin Invest1982https://conductscience.org/library/papers/6976356PubMed
6965944Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.J Clin Invest1980https://conductscience.org/library/papers/6965944PubMed
6712306Effects of D-penicillamine on growth and cell cycle kinetics of cultured rabbit articular chondrocytes.Ann Rheum Dis1984https://conductscience.org/library/papers/6712306PubMed
6606652Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.J Clin Invest1984https://conductscience.org/library/papers/6606652PubMed
6323541Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.J Clin Invest1984https://conductscience.org/library/papers/6323541PubMed
3882062Evidence against HLA and immunological dependence of disease outbreak in SLE. Immunological characterisation of identical twins clinically discordant for SLE.Ann Rheum Dis1985https://conductscience.org/library/papers/3882062PubMed
3872635Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects.Ann Rheum Dis1985https://conductscience.org/library/papers/3872635PubMed
3653951Indian childhood cirrhosis: copper ingestion, penicillamine treatment and prevention.Indian J Pediatr1987https://conductscience.org/library/papers/3653951PubMed
3189044Proteoglycan biosynthesis by rabbit articular chondrocytes treated with D-penicillamine.Agents Actions1988https://conductscience.org/library/papers/3189044PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/632576

GET https://conductscience.org/api/papers/v1/632576/cited_by?page=2